Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Long-term Follow-up Study for Patients Treated With Galapagos CAR T-cell Therapies

NCT06652633 is registered in ClinicalTrials.gov with Lakefront Biotherapeutics NV as lead sponsor.

NCT NCT06652633
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06652633 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Long-term Follow-up Study for Patients Treated With Galapagos CAR T-cell Therapies
Lead sponsor
Lakefront Biotherapeutics NV
Phase
Phase 3
Overall status
Recruiting
Start date
September 9, 2024
Completion date
July 31, 2039
Enrollment
546 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

hematological malignancies